Aptamer Group (LSE:APTA) Accounts Receivable : £0.02 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Aptamer Group's accounts receivables for the quarter that ended in Dec. 2023 was £0.02 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Aptamer Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 14.09.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Aptamer Group's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was £-0.00.

Aptamer Group Accounts Receivable Historical Data

The historical data trend for Aptamer Group's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Accounts Receivable Chart

Aptamer Group Annual Data

Trend

Mar19

Mar20

Jun22

Jun23

Accounts Receivable

0.20

0.30

0.63

0.36

Aptamer Group Semi-Annual Data
	Mar19	Mar20	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Receivable	Get a 7-Day Free Trial			1.37	0.63	0.75	0.36	0.02

Aptamer Group Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Aptamer Group Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Aptamer Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.023	/	0.298	*	91
=	14.09

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Aptamer Group's accounts receivable are only considered to be worth 75% of book value:

Aptamer Group's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1.756	+	0.75 * 0.023	+	0.5 * 0.132	-	1.978
-	0	-	0)	/	467.344
=	-0.00

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Aptamer Group Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Aptamer Group's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptamer Group (LSE:APTA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Innovation Way, Windmill House, York, GBR, YO10 5BR

Website

https://www.aptamergroup.com

Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group (LSE:APTA) Headlines

No Headlines